Sickle Cell Disease Comprehensive Care Act
- Last Action
- 3/31/2023
Actions
- 2023-03-31Referred to the Subcommittee on Health.
- 2023-03-21Referred to the House Committee on Energy and Commerce.
- 2023-03-21Introduced in House
- 2023-03-21Introduced in House
CRS Summary
As of 2023-03-21 (00)
Sickle Cell Disease Comprehensive Care Act
This bill establishes and provides funds for a demonstration project for state Medicaid programs to improve outpatient care for individuals with sickle cell disease, with a focus on young adults and pregnant women.
The Centers for Medicare & Medicaid Services must award planning grants to at least 10 states and must select between 5 and 10 states to participate in the project. Participating states must provide specified services and support for individuals with sickle cell disease, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services.
The bill provides a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided through the project.
Cosponsors (4)
- Michael Burgess (R-TX)
- BARBARA LEE (D-CA)
- Daniel Kildee (D-MI)
- Troy Carter (D-LA)
Subjects
- Blood and blood diseases
- Congressional oversight
- Government information and archives
- Health care coverage and access
- Health information and medical records
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Hereditary and development disorders
- Home and outpatient care
- Intergovernmental relations
- Medicaid
- Minority health
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.